Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients

J. Orsag, D. Karasek, M. Halenka, H. Vaverkova, J. Spurna, V. Kubickova, J. Lukes, J. Zadrazil

. 2019 ; 163 (2) : 166-171. [pub] 20180911

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028265

BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028265
003      
CZ-PrNML
005      
20220104150635.0
007      
ta
008      
211105s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.043 $2 doi
035    __
$a (PubMed)30209438
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Orság, Jiří $7 xx0229430 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
245    10
$a Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients / $c J. Orsag, D. Karasek, M. Halenka, H. Vaverkova, J. Spurna, V. Kubickova, J. Lukes, J. Zadrazil
504    __
$a Literatura
520    9_
$a BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.
650    _2
$a dospělí $7 D000328
650    _2
$a apolipoprotein A-I $x krev $7 D016632
650    _2
$a apolipoprotein B-100 $x krev $7 D053299
650    _2
$a ateroskleróza $x krev $x diagnostické zobrazování $7 D050197
650    _2
$a nemoci arterie carotis $x krev $x diagnostické zobrazování $7 D002340
650    _2
$a arteria carotis communis $x diagnostické zobrazování $7 D017536
650    _2
$a intimomediální šíře tepenné stěny $7 D059168
650    _2
$a dyslipidemie $x krev $x diagnostické zobrazování $7 D050171
650    _2
$a proteiny vázající mastné kyseliny $x krev $7 D050556
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a inzulinová rezistence $7 D007333
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x krev $x diagnostické zobrazování $7 D024821
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
700    1_
$a Karásek, David $7 stk2007415300 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Halenka, Milan $7 xx0047393 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Vaverková, Helena, $d 1942- $7 nlk20000083882 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Spurná, Jaromíra $7 xx0227678 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
700    1_
$a Kubíčková, Veronika $7 xx0225011 $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic Corresponding author: Jiri Orsag, e-mail
700    1_
$a Lukeš, Jiří $7 xx0070976 $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic
700    1_
$a Zadražil, Josef, $d 1954- $7 xx0074493 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 163, č. 2 (2019), s. 166-171
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30209438 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20220104150630 $b ABA008
999    __
$a ok $b bmc $g 1742226 $s 1148810
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 163 $c 2 $d 166-171 $e 20180911 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...